UBS O'Connor’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,258
| Closed | -$372K | – | 296 |
|
|
2025
Q1 | $372K | Sell |
5,258
-21,582
| -80% | -$1.53M | 0.01% | 211 |
|
|
2024
Q4 | $1.76M | Buy |
+26,840
| New | +$1.76M | 0.05% | 165 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 418 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 453 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 443 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 441 |
|
|
2016
Q3 | – | Sell |
-15,000
| Closed | -$1.17M | – | 389 |
|
|
2016
Q2 | $1.17M | Buy |
15,000
+2,938
| +24% | +$229K | 0.03% | 283 |
|
|
2016
Q1 | $995K | Buy |
+12,062
| New | +$995K | 0.02% | 311 |
|
|
2014
Q2 | – | Sell |
-17,500
| Closed | -$1.19M | – | 408 |
|
|
2014
Q1 | $1.19M | Buy |
+17,500
| New | +$1.19M | 0.02% | 311 |
|
|
2013
Q3 | – | Sell |
-47,000
| Closed | -$2.62M | – | 356 |
|
|
2013
Q2 | $2.62M | Buy |
+47,000
| New | +$2.62M | 0.05% | 299 |
|